CD19 and lymphoma: This work aims to provide a proof-of-concept to evaluate the relevance of the chicken CAM assay by testing the efficacy of CD19-targeting CAR-T-cell products developed by Allogenica (France) on human lymphoma originating from the Raji cell line.